Pia Paffenholz
Kerpener Str. 62
Koeln, NW 50937, Germany
Koeln, NW 50937, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Testicular Germ Cell Tumors and Penile Cancer: Molecular-Based Diagnosis and Treatment
Journal: Aktuelle Urologie
Published: July 30, 2026
Diagnosis and treatment of upper tract urothelial carcinoma: assessment of guideline compliance from 2011-2024
Journal: Urologie (Heidelberg, Germany)
Published: February 20, 2026
Effectiveness and safety of enfortumab vedotin and pembrolizumab in a real-world patient population with urothelial carcinoma: results from a multi-institutional cohort (GUARDIANS).
Journal: Cancer immunology, immunotherapy : CII
Published: February 16, 2026
Clinical characteristics, treatment patterns, and survival outcomes in ductal prostate cancer: a multicenter retrospective analysis.
Journal: World journal of urology
Published: February 12, 2026
Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
How Often are druggable mutations detectable in Metastatic Castration Resistant Prostate Cancer?
Journal: Urologia internationalis
Published: January 11, 2026
Hereditary kidney tumor syndromes: structured evaluation of a questionnaire-based approach.
Journal: Clinical kidney journal
Published: December 02, 2025
Progression-free survival with darolutamide and docetaxel vs. androgen receptor pathway inhibitors vs. docetaxel in metastatic hormone-sensitive prostate cancer: A real-world multicenter retrospective study.
Journal: Urologic oncology
Published: September 21, 2025
Expression and therapeutic potential of TROP2 in cisplatin-resistant germ cell tumors.
Journal: Journal of cancer research and clinical oncology
Published: August 06, 2025
Comparison of glass-based and whole-slide image-based grade assignment for clear-cell and papillary renal cell carcinoma: a multi-cohort, international reproducibility study.
Journal: Histopathology
Published: July 07, 2025
Real-world efficacy and toxicity of ipilimumab and nivolumab as a first-line treatment for advanced renal cell carcinoma according to IMDC risk criteria-A multi-center retrospective analysis on behalf of the GUARDIANS group.
Journal: International journal of cancer
Published: July 03, 2025
Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project.
Journal: European urology open science
Published: June 22, 2025
Last Updated: 09/26/2026